Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer's disease. 2023

Bruna Bellaver, and Guilherme Povala, and Pamela C L Ferreira, and João Pedro Ferrari-Souza, and Douglas T Leffa, and Firoza Z Lussier, and Andréa L Benedet, and Nicholas J Ashton, and Gallen Triana-Baltzer, and Hartmuth C Kolb, and Cécile Tissot, and Joseph Therriault, and Stijn Servaes, and Jenna Stevenson, and Nesrine Rahmouni, and Oscar L Lopez, and Dana L Tudorascu, and Victor L Villemagne, and Milos D Ikonomovic, and Serge Gauthier, and Eduardo R Zimmer, and Henrik Zetterberg, and Kaj Blennow, and Howard J Aizenstein, and William E Klunk, and Beth E Snitz, and Pauline Maki, and Rebecca C Thurston, and Ann D Cohen, and Mary Ganguli, and Thomas K Karikari, and Pedro Rosa-Neto, and Tharick A Pascoal
Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.

An unresolved question for the understanding of Alzheimer's disease (AD) pathophysiology is why a significant percentage of amyloid-β (Aβ)-positive cognitively unimpaired (CU) individuals do not develop detectable downstream tau pathology and, consequently, clinical deterioration. In vitro evidence suggests that reactive astrocytes unleash Aβ effects in pathological tau phosphorylation. Here, in a biomarker study across three cohorts (n = 1,016), we tested whether astrocyte reactivity modulates the association of Aβ with tau phosphorylation in CU individuals. We found that Aβ was associated with increased plasma phosphorylated tau only in individuals positive for astrocyte reactivity (Ast+). Cross-sectional and longitudinal tau-positron emission tomography analyses revealed an AD-like pattern of tau tangle accumulation as a function of Aβ only in CU Ast+ individuals. Our findings suggest astrocyte reactivity as an important upstream event linking Aβ with initial tau pathology, which may have implications for the biological definition of preclinical AD and for selecting CU individuals for clinical trials.

UI MeSH Term Description Entries
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D001253 Astrocytes A class of large neuroglial (macroglial) cells in the central nervous system - the largest and most numerous neuroglial cells in the brain and spinal cord. Astrocytes (from "star" cells) are irregularly shaped with many long processes, including those with "end feet" which form the glial (limiting) membrane and directly and indirectly contribute to the BLOOD-BRAIN BARRIER. They regulate the extracellular ionic and chemical environment, and "reactive astrocytes" (along with MICROGLIA) respond to injury. Astroglia,Astroglia Cells,Astroglial Cells,Astrocyte,Astroglia Cell,Astroglial Cell,Astroglias,Cell, Astroglia,Cell, Astroglial
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D016229 Amyloid beta-Peptides Peptides generated from AMYLOID BETA-PEPTIDES PRECURSOR. An amyloid fibrillar form of these peptides is the major component of amyloid plaques found in individuals with Alzheimer's disease and in aged individuals with trisomy 21 (DOWN SYNDROME). The peptide is found predominantly in the nervous system, but there have been reports of its presence in non-neural tissue. Alzheimer beta-Protein,Amyloid Protein A4,Amyloid beta-Peptide,Amyloid beta-Protein,beta Amyloid,beta-Amyloid Protein,Alzheimer's ABP,Alzheimer's Amyloid Fibril Protein,Amyloid AD-AP,Amyloid Fibril Protein, Alzheimer's,Amyloid beta-Proteins,ABP, Alzheimer's,AD-AP, Amyloid,Alzheimer ABP,Alzheimer beta Protein,Alzheimers ABP,Amyloid AD AP,Amyloid beta Peptide,Amyloid beta Peptides,Amyloid beta Protein,Amyloid beta Proteins,Amyloid, beta,Protein A4, Amyloid,Protein, beta-Amyloid,beta Amyloid Protein,beta-Peptide, Amyloid,beta-Peptides, Amyloid,beta-Protein, Alzheimer,beta-Protein, Amyloid,beta-Proteins, Amyloid
D016875 tau Proteins Microtubule-associated proteins that are mainly expressed in neurons. Tau proteins constitute several isoforms and play an important role in the assembly of tubulin monomers into microtubules and in maintaining the cytoskeleton and axonal transport. Aggregation of specific sets of tau proteins in filamentous inclusions is the common feature of intraneuronal and glial fibrillar lesions (NEUROFIBRILLARY TANGLES; NEUROPIL THREADS) in numerous neurodegenerative disorders (ALZHEIMER DISEASE; TAUOPATHIES). tau Protein,Protein, tau,Proteins, tau
D049268 Positron-Emission Tomography An imaging technique using compounds labelled with short-lived positron-emitting radionuclides (such as carbon-11, nitrogen-13, oxygen-15 and fluorine-18) to measure cell metabolism. It has been useful in study of soft tissues such as CANCER; CARDIOVASCULAR SYSTEM; and brain. SINGLE-PHOTON EMISSION-COMPUTED TOMOGRAPHY is closely related to positron emission tomography, but uses isotopes with longer half-lives and resolution is lower. PET Imaging,PET Scan,Positron-Emission Tomography Imaging,Tomography, Positron-Emission,Imaging, PET,Imaging, Positron-Emission Tomography,PET Imagings,PET Scans,Positron Emission Tomography,Positron Emission Tomography Imaging,Positron-Emission Tomography Imagings,Scan, PET,Tomography Imaging, Positron-Emission,Tomography, Positron Emission
D060825 Cognitive Dysfunction Diminished or impaired mental and/or intellectual function. Cognitive Disorder,Mild Cognitive Impairment,Cognitive Decline,Cognitive Impairments,Mental Deterioration,Cognitive Declines,Cognitive Disorders,Cognitive Dysfunctions,Cognitive Impairment,Cognitive Impairment, Mild,Cognitive Impairments, Mild,Decline, Cognitive,Declines, Cognitive,Deterioration, Mental,Deteriorations, Mental,Disorder, Cognitive,Disorders, Cognitive,Dysfunction, Cognitive,Dysfunctions, Cognitive,Impairment, Cognitive,Impairment, Mild Cognitive,Impairments, Cognitive,Impairments, Mild Cognitive,Mental Deteriorations,Mild Cognitive Impairments

Related Publications

Bruna Bellaver, and Guilherme Povala, and Pamela C L Ferreira, and João Pedro Ferrari-Souza, and Douglas T Leffa, and Firoza Z Lussier, and Andréa L Benedet, and Nicholas J Ashton, and Gallen Triana-Baltzer, and Hartmuth C Kolb, and Cécile Tissot, and Joseph Therriault, and Stijn Servaes, and Jenna Stevenson, and Nesrine Rahmouni, and Oscar L Lopez, and Dana L Tudorascu, and Victor L Villemagne, and Milos D Ikonomovic, and Serge Gauthier, and Eduardo R Zimmer, and Henrik Zetterberg, and Kaj Blennow, and Howard J Aizenstein, and William E Klunk, and Beth E Snitz, and Pauline Maki, and Rebecca C Thurston, and Ann D Cohen, and Mary Ganguli, and Thomas K Karikari, and Pedro Rosa-Neto, and Tharick A Pascoal
November 2022, Molecular psychiatry,
Bruna Bellaver, and Guilherme Povala, and Pamela C L Ferreira, and João Pedro Ferrari-Souza, and Douglas T Leffa, and Firoza Z Lussier, and Andréa L Benedet, and Nicholas J Ashton, and Gallen Triana-Baltzer, and Hartmuth C Kolb, and Cécile Tissot, and Joseph Therriault, and Stijn Servaes, and Jenna Stevenson, and Nesrine Rahmouni, and Oscar L Lopez, and Dana L Tudorascu, and Victor L Villemagne, and Milos D Ikonomovic, and Serge Gauthier, and Eduardo R Zimmer, and Henrik Zetterberg, and Kaj Blennow, and Howard J Aizenstein, and William E Klunk, and Beth E Snitz, and Pauline Maki, and Rebecca C Thurston, and Ann D Cohen, and Mary Ganguli, and Thomas K Karikari, and Pedro Rosa-Neto, and Tharick A Pascoal
January 2019, Journal of Alzheimer's disease : JAD,
Bruna Bellaver, and Guilherme Povala, and Pamela C L Ferreira, and João Pedro Ferrari-Souza, and Douglas T Leffa, and Firoza Z Lussier, and Andréa L Benedet, and Nicholas J Ashton, and Gallen Triana-Baltzer, and Hartmuth C Kolb, and Cécile Tissot, and Joseph Therriault, and Stijn Servaes, and Jenna Stevenson, and Nesrine Rahmouni, and Oscar L Lopez, and Dana L Tudorascu, and Victor L Villemagne, and Milos D Ikonomovic, and Serge Gauthier, and Eduardo R Zimmer, and Henrik Zetterberg, and Kaj Blennow, and Howard J Aizenstein, and William E Klunk, and Beth E Snitz, and Pauline Maki, and Rebecca C Thurston, and Ann D Cohen, and Mary Ganguli, and Thomas K Karikari, and Pedro Rosa-Neto, and Tharick A Pascoal
October 2021, Molecular psychiatry,
Bruna Bellaver, and Guilherme Povala, and Pamela C L Ferreira, and João Pedro Ferrari-Souza, and Douglas T Leffa, and Firoza Z Lussier, and Andréa L Benedet, and Nicholas J Ashton, and Gallen Triana-Baltzer, and Hartmuth C Kolb, and Cécile Tissot, and Joseph Therriault, and Stijn Servaes, and Jenna Stevenson, and Nesrine Rahmouni, and Oscar L Lopez, and Dana L Tudorascu, and Victor L Villemagne, and Milos D Ikonomovic, and Serge Gauthier, and Eduardo R Zimmer, and Henrik Zetterberg, and Kaj Blennow, and Howard J Aizenstein, and William E Klunk, and Beth E Snitz, and Pauline Maki, and Rebecca C Thurston, and Ann D Cohen, and Mary Ganguli, and Thomas K Karikari, and Pedro Rosa-Neto, and Tharick A Pascoal
January 2017, Translational psychiatry,
Bruna Bellaver, and Guilherme Povala, and Pamela C L Ferreira, and João Pedro Ferrari-Souza, and Douglas T Leffa, and Firoza Z Lussier, and Andréa L Benedet, and Nicholas J Ashton, and Gallen Triana-Baltzer, and Hartmuth C Kolb, and Cécile Tissot, and Joseph Therriault, and Stijn Servaes, and Jenna Stevenson, and Nesrine Rahmouni, and Oscar L Lopez, and Dana L Tudorascu, and Victor L Villemagne, and Milos D Ikonomovic, and Serge Gauthier, and Eduardo R Zimmer, and Henrik Zetterberg, and Kaj Blennow, and Howard J Aizenstein, and William E Klunk, and Beth E Snitz, and Pauline Maki, and Rebecca C Thurston, and Ann D Cohen, and Mary Ganguli, and Thomas K Karikari, and Pedro Rosa-Neto, and Tharick A Pascoal
February 2017, Molecular psychiatry,
Bruna Bellaver, and Guilherme Povala, and Pamela C L Ferreira, and João Pedro Ferrari-Souza, and Douglas T Leffa, and Firoza Z Lussier, and Andréa L Benedet, and Nicholas J Ashton, and Gallen Triana-Baltzer, and Hartmuth C Kolb, and Cécile Tissot, and Joseph Therriault, and Stijn Servaes, and Jenna Stevenson, and Nesrine Rahmouni, and Oscar L Lopez, and Dana L Tudorascu, and Victor L Villemagne, and Milos D Ikonomovic, and Serge Gauthier, and Eduardo R Zimmer, and Henrik Zetterberg, and Kaj Blennow, and Howard J Aizenstein, and William E Klunk, and Beth E Snitz, and Pauline Maki, and Rebecca C Thurston, and Ann D Cohen, and Mary Ganguli, and Thomas K Karikari, and Pedro Rosa-Neto, and Tharick A Pascoal
August 2021, Progress in neurobiology,
Bruna Bellaver, and Guilherme Povala, and Pamela C L Ferreira, and João Pedro Ferrari-Souza, and Douglas T Leffa, and Firoza Z Lussier, and Andréa L Benedet, and Nicholas J Ashton, and Gallen Triana-Baltzer, and Hartmuth C Kolb, and Cécile Tissot, and Joseph Therriault, and Stijn Servaes, and Jenna Stevenson, and Nesrine Rahmouni, and Oscar L Lopez, and Dana L Tudorascu, and Victor L Villemagne, and Milos D Ikonomovic, and Serge Gauthier, and Eduardo R Zimmer, and Henrik Zetterberg, and Kaj Blennow, and Howard J Aizenstein, and William E Klunk, and Beth E Snitz, and Pauline Maki, and Rebecca C Thurston, and Ann D Cohen, and Mary Ganguli, and Thomas K Karikari, and Pedro Rosa-Neto, and Tharick A Pascoal
November 2018, Translational psychiatry,
Bruna Bellaver, and Guilherme Povala, and Pamela C L Ferreira, and João Pedro Ferrari-Souza, and Douglas T Leffa, and Firoza Z Lussier, and Andréa L Benedet, and Nicholas J Ashton, and Gallen Triana-Baltzer, and Hartmuth C Kolb, and Cécile Tissot, and Joseph Therriault, and Stijn Servaes, and Jenna Stevenson, and Nesrine Rahmouni, and Oscar L Lopez, and Dana L Tudorascu, and Victor L Villemagne, and Milos D Ikonomovic, and Serge Gauthier, and Eduardo R Zimmer, and Henrik Zetterberg, and Kaj Blennow, and Howard J Aizenstein, and William E Klunk, and Beth E Snitz, and Pauline Maki, and Rebecca C Thurston, and Ann D Cohen, and Mary Ganguli, and Thomas K Karikari, and Pedro Rosa-Neto, and Tharick A Pascoal
August 2017, Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry,
Bruna Bellaver, and Guilherme Povala, and Pamela C L Ferreira, and João Pedro Ferrari-Souza, and Douglas T Leffa, and Firoza Z Lussier, and Andréa L Benedet, and Nicholas J Ashton, and Gallen Triana-Baltzer, and Hartmuth C Kolb, and Cécile Tissot, and Joseph Therriault, and Stijn Servaes, and Jenna Stevenson, and Nesrine Rahmouni, and Oscar L Lopez, and Dana L Tudorascu, and Victor L Villemagne, and Milos D Ikonomovic, and Serge Gauthier, and Eduardo R Zimmer, and Henrik Zetterberg, and Kaj Blennow, and Howard J Aizenstein, and William E Klunk, and Beth E Snitz, and Pauline Maki, and Rebecca C Thurston, and Ann D Cohen, and Mary Ganguli, and Thomas K Karikari, and Pedro Rosa-Neto, and Tharick A Pascoal
January 2023, Molecular neurodegeneration,
Bruna Bellaver, and Guilherme Povala, and Pamela C L Ferreira, and João Pedro Ferrari-Souza, and Douglas T Leffa, and Firoza Z Lussier, and Andréa L Benedet, and Nicholas J Ashton, and Gallen Triana-Baltzer, and Hartmuth C Kolb, and Cécile Tissot, and Joseph Therriault, and Stijn Servaes, and Jenna Stevenson, and Nesrine Rahmouni, and Oscar L Lopez, and Dana L Tudorascu, and Victor L Villemagne, and Milos D Ikonomovic, and Serge Gauthier, and Eduardo R Zimmer, and Henrik Zetterberg, and Kaj Blennow, and Howard J Aizenstein, and William E Klunk, and Beth E Snitz, and Pauline Maki, and Rebecca C Thurston, and Ann D Cohen, and Mary Ganguli, and Thomas K Karikari, and Pedro Rosa-Neto, and Tharick A Pascoal
April 2020, Experimental & molecular medicine,
Copied contents to your clipboard!